US Stock MarketDetailed Quotes
INFIQ Infinity Pharmaceuticals
- 0.000
- +0.000+900.00%
15min DelayClose Dec 20 16:00 ET
- 0.000
- 0.0000.00%
Post 17:01 ET
907.61Market Cap0.00P/E (TTM)
0.000High0.000Low19.13KVolume0.000Open0.000Pre Close0.19Turnover0.02%Turnover Ratio0.00P/E (Static)90.76MShares0.01852wk High0.00P/B894.85Float Cap0.00052wk Low--Dividend TTM89.49MShs Float104.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
About Infinity Pharmaceuticals Company
Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing novel medicines for people with cancer. It focuses on its drug development segment. The company was founded by Steven H. Holtzman and Matthew D. Shair on March 22, 1995 and is headquartered in Cambridge, MA.
Company Profile
SymbolINFIQ
Company NameInfinity Pharmaceuticals
Listing DateJul 27, 2000
Founded1995
CEOMr. Seth A. Tasker, J.D.
MarketPink Market
Employees30
Fiscal Year Ends12-31
Address1100 Massachusetts Avenue,4th Floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02138
Phone1-617-453-1000
Websitehttp://www.infi.com
Company Executives
- Name
- Position
- Salary
- Seth A. Tasker, J.D.
- Chief Executive Officer
- --
- Adelene Q. Perkins
- Chairman of the Board
- --
- David William Beier, J.D.
- Independent Director
- --
- Norman C. Selby
- Lead Independent Director
- --
- Dr. Richard B. Gaynor, M.D.
- Independent Director
- --
- Dr. Anthony B. Evnin,PhD
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data
